Author:
Iwaki Noriko,Sato Yasuharu,Takata Katsuyoshi,Kondo Eisei,Ohno Kyotaro,Takeuchi Mai,Orita Yorihisa,Nakao Shinji,Yoshino Tadashi
Publisher
Japanese Society for Lymphoreticular Tissue Research
Reference30 articles.
1. 1 Castleman B, Iverson L, Menendez VP: Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9:822-830, 1956
2. 2 Frizzera G, Peterson BA, Bayrd ED, Goldman A: A systemic lymphoproliferative disorder with morphologic features of Castleman's disease : clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216, 1985
3. 3 Frizzera G: Castleman's disease and related disorders. Semin Diagn Pathol 5:346-364, 1988
4. 4 Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670-683, 1972
5. 5 Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, et al.: Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman' disease : a clinicopathologic study of five cases. Pathol Res Pract 193:565-571, 1997
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report;Modern Rheumatology Case Reports;2024-08-23
2. TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly;Biomedicines;2024-06-08
3. A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction;Cureus;2024-04-22
4. Immune‐mediated thrombocytopenia and IL‐6‐mediated thrombocytosis observed in idiopathic multicentric Castleman disease;British Journal of Haematology;2024-01-02
5. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel;HemaSphere;2023-05-23